Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses.

Braithwaite D, Walter LC, Izano M, Kerlikowske K.

J Gen Intern Med. 2016 May;31(5):561-72. doi: 10.1007/s11606-015-3580-3. Review.

PMID:
26831305
2.

Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.

van Ravesteyn NT, Stout NK, Schechter CB, Heijnsdijk EA, Alagoz O, Trentham-Dietz A, Mandelblatt JS, de Koning HJ.

J Natl Cancer Inst. 2015 May 6;107(7). pii: djv103. doi: 10.1093/jnci/djv103.

3.

Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits.

Lansdorp-Vogelaar I, Gulati R, Mariotto AB, Schechter CB, de Carvalho TM, Knudsen AB, van Ravesteyn NT, Heijnsdijk EA, Pabiniak C, van Ballegooijen M, Rutter CM, Kuntz KM, Feuer EJ, Etzioni R, de Koning HJ, Zauber AG, Mandelblatt JS.

Ann Intern Med. 2014 Jul 15;161(2):104-12. doi: 10.7326/M13-2867.

4.

Screening mammography in older women: a review.

Walter LC, Schonberg MA.

JAMA. 2014 Apr 2;311(13):1336-47. doi: 10.1001/jama.2014.2834. Review.

5.

To screen or not to screen older women for breast cancer: a conundrum.

Braithwaite D, Mandelblatt JS, Kerlikowske K.

Future Oncol. 2013 Jun;9(6):763-6. doi: 10.2217/fon.13.64. No abstract available.

6.

Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K; Breast Cancer Surveillance Consortium..

J Natl Cancer Inst. 2013 Mar 6;105(5):334-41. doi: 10.1093/jnci/djs645.

7.

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.

Cott Chubiz JE, Lee JM, Gilmore ME, Kong CY, Lowry KP, Halpern EF, McMahon PM, Ryan PD, Gazelle GS.

Cancer. 2013 Mar 15;119(6):1266-76. doi: 10.1002/cncr.27864.

8.

Cancer surgery in the elderly.

Kowdley GC, Merchant N, Richardson JP, Somerville J, Gorospe M, Cunningham SC.

ScientificWorldJournal. 2012;2012:303852. doi: 10.1100/2012/303852. Review.

9.

Breast cancer screening trends in the United States and ethnicity.

Miranda PY, Tarraf W, González P, Johnson-Jennings M, González HM.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):351-7. doi: 10.1158/1055-9965.EPI-11-0873.

10.

Modeling the impact of population screening on breast cancer mortality in the United States.

Mandelblatt JS, Cronin KA, Berry DA, Chang Y, de Koning HJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, van Ravesteyn NT, Zelen M, Feuer EJ.

Breast. 2011 Oct;20 Suppl 3:S75-81. doi: 10.1016/S0960-9776(11)70299-5.

11.

Mammography screening trends: the perspective of African American women born pre/post World War II.

Williams KP, Mabiso A, Lo YJ, Penner LA.

J Natl Med Assoc. 2010 Jun;102(6):452-60.

12.

Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model.

Furiak NM, Klein RW, Kahle-Wrobleski K, Siemers ER, Sarpong E, Klein TM.

BMC Med Inform Decis Mak. 2010 Apr 30;10:24. doi: 10.1186/1472-6947-10-24.

14.

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.

Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network..

Ann Intern Med. 2009 Nov 17;151(10):738-47. doi: 10.7326/0003-4819-151-10-200911170-00010. Erratum in: Ann Intern Med. 2010 Jan 19;152(2):136.

15.

Cost-effectiveness analysis of mammography and clinical breast examination strategies: a comparison with current guidelines.

Ahern CH, Shen Y.

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):718-25. doi: 10.1158/1055-9965.EPI-08-0918.

16.

Weighing the benefits and burdens of mammography screening among women age 80 years or older.

Schonberg MA, Silliman RA, Marcantonio ER.

J Clin Oncol. 2009 Apr 10;27(11):1774-80. doi: 10.1200/JCO.2008.19.9877.

17.

Decision making and counseling around mammography screening for women aged 80 or older.

Schonberg MA, Ramanan RA, McCarthy EP, Marcantonio ER.

J Gen Intern Med. 2006 Sep;21(9):979-85.

18.
Items per page

Supplemental Content

Support Center